Pages that link to "Q33198320"
Jump to navigation
Jump to search
The following pages link to The contribution of epidermal growth factor receptor (EGFR) signaling pathway to radioresistance in human gliomas: a review of preclinical and correlative clinical data. (Q33198320):
Displaying 50 items.
- Radioresistance of Brain Tumors (Q26752579) (← links)
- PI3K/Akt/mTOR signaling pathway and targeted therapy for glioblastoma (Q26766293) (← links)
- Magnetic nanoparticles: an emerging technology for malignant brain tumor imaging and therapy (Q27004205) (← links)
- Nuclear EGFRvIII-STAT5b complex contributes to glioblastoma cell survival by direct activation of the Bcl-XL promoter (Q30416775) (← links)
- Angiogenesis in gliomas: imaging and experimental therapeutics (Q31028310) (← links)
- Analysis of differentially expressed genes based on microarray data of glioma (Q31037039) (← links)
- Growth inhibition and radiosensitization of glioblastoma and lung cancer cells by small interfering RNA silencing of tumor necrosis factor receptor-associated factor 2. (Q33369696) (← links)
- Thermodynamics in Gliomas: Interactions between the Canonical WNT/Beta-Catenin Pathway and PPAR Gamma (Q33748280) (← links)
- 3,3'-Diindolylmethane (DIM) inhibits the growth and invasion of drug-resistant human cancer cells expressing EGFR mutants (Q33937876) (← links)
- Clinically relevant doses of chemotherapy agents reversibly block formation of glioblastoma neurospheres. (Q34037067) (← links)
- Regulation of DNA Repair Mechanism in Human Glioma Xenograft Cells both In Vitro and In Vivo in Nude Mice (Q34056137) (← links)
- Phase I study of vandetanib during and after radiotherapy in children with diffuse intrinsic pontine glioma (Q34488803) (← links)
- The prospective application of a hypoxic radiosensitizer, doranidazole to rat intracranial glioblastoma with blood brain barrier disruption. (Q34621903) (← links)
- Lin28 mediates radiation resistance of breast cancer cells via regulation of caspase, H2A.X and Let-7 signaling (Q34807238) (← links)
- Induction of the unfolded protein response drives enhanced metabolism and chemoresistance in glioma cells (Q34988108) (← links)
- A leak pathway for luminal protons in endosomes drives oncogenic signalling in glioblastoma (Q35162374) (← links)
- Radiation-induced PGE2 sustains human glioma cells growth and survival through EGF signaling. (Q35740087) (← links)
- 1H NMR metabolomics analysis of glioblastoma subtypes: correlation between metabolomics and gene expression characteristics (Q36016852) (← links)
- Targeted molecular therapy of malignant gliomas (Q36113026) (← links)
- Novel therapeutics in adult malignant brain gliomas (Q36187046) (← links)
- Cytotoxic and molecular chemotherapy for high-grade glioma: an emerging strategy for the future (Q36429731) (← links)
- Malignant gliomas: strategies to increase the effectiveness of targeted molecular treatment (Q36499234) (← links)
- Epidermal growth factor receptor inhibition and non-small cell lung cancer (Q36504349) (← links)
- Designing clinical trials for brain tumors: the next generation (Q36681517) (← links)
- Impact of molecular profiling on clinical trial design for glioblastoma. (Q36681532) (← links)
- Inhibiting kinases in malignant gliomas (Q36764876) (← links)
- Molecularly targeted therapies for malignant gliomas: advances and challenges (Q36817109) (← links)
- Molecularly targeted therapy for malignant glioma (Q36829847) (← links)
- New developments in the treatment of malignant gliomas (Q36972696) (← links)
- Molecular strategies for the treatment of malignant glioma--genes, viruses, and vaccines (Q37079854) (← links)
- Combining molecular targeted agents with radiation therapy for malignant gliomas (Q37099863) (← links)
- Antiangiogenic therapy in brain tumors (Q37129915) (← links)
- EGFRvIII and DNA double-strand break repair: a molecular mechanism for radioresistance in glioblastoma (Q37223890) (← links)
- Combination therapy for malignant glioma based on PTEN status (Q37316986) (← links)
- Gene therapy for colorectal cancer using adenovirus-mediated full-length antibody, cetuximab (Q37317530) (← links)
- Pharmacotherapy for adults with tumors of the central nervous system (Q37353276) (← links)
- Targeting EGFR resistance networks in head and neck cancer. (Q37405633) (← links)
- Phase-1 trial of gefitinib and temozolomide in patients with malignant glioma: a North American brain tumor consortium study (Q37414810) (← links)
- Towards tailored therapy of glioblastoma multiforme (Q37908815) (← links)
- Molecularly targeted therapy in neuro-oncology (Q37974367) (← links)
- Angiogenesis in neurological disorders: a review (Q38034321) (← links)
- Lapatinib with whole brain radiotherapy in patients with brain metastases from breast and non-small cell lung cancer: a phase II study of the Hellenic Cooperative Oncology Group (HeCOG). (Q38688750) (← links)
- The unfolded protein response in glioblastomas: targetable or trouble? (Q38970037) (← links)
- Combined EGFR and autophagy modulation impairs cell migration and enhances radiosensitivity in human glioblastoma cells (Q39009280) (← links)
- Insights into molecular therapy of glioma: current challenges and next generation blueprint (Q39187306) (← links)
- Temozolomide-mediated radiosensitization of human glioma cells in a zebrafish embryonic system (Q39583530) (← links)
- EGFRvIII antibody-conjugated iron oxide nanoparticles for magnetic resonance imaging-guided convection-enhanced delivery and targeted therapy of glioblastoma (Q39677767) (← links)
- Gene silencing for epidermal growth factor receptor variant III induces cell-specific cytotoxicity (Q39918802) (← links)
- Pro-survival AKT and ERK signaling from EGFR and mutant EGFRvIII enhances DNA double-strand break repair in human glioma cells (Q40323053) (← links)
- Combined epidermal growth factor receptor and Beclin1 autophagic protein expression analysis identifies different clinical presentations, responses to chemo- and radiotherapy, and prognosis in glioblastoma. (Q41142096) (← links)